日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction to "In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-Radioimmunotherapy"

对“用于α和β放射免疫疗法的双功能螯合剂与CD33结合抗体随机偶联和位点特异性偶联的体外和体内比较”一文的更正

Allen, Kevin J H; Frank, Connor; Jiao, Rubin; Malo, Mackenzie E; Bello, Michele; De Nardo, Laura; Meléndez-Alafort, Laura; Dadachova, Ekaterina

In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-Radioimmunotherapy.

体外和体内比较双功能螯合剂与 CD33 结合抗体随机偶联和位点特异性偶联在 α 和 β 放射免疫疗法中的应用

Allen Kevin J H, Frank Connor, Jiao Rubin, Malo Mackenzie E, Bello Michele, De Nardo Laura, Meléndez-Alafort Laura, Dadachova Ekaterina

(155)Tb production by cyclotrons: what level of (155)Gd enrichment allows clinical applications?

利用回旋加速器生产 (155)Tb:(155)Gd 的富集程度达到什么水平才能应用于临床?

Barbaro, Francesca; Canton, Luciano; Uzunov, Nikolay; De Nardo, Laura; Melendez-Alafort, Laura

Nuclear Cross-Section of Proton-Induced Reactions on Enriched (48)Ti Targets for the Production of Theranostic (47)Sc Radionuclide, (46c)Sc, (44m)Sc, (44g)Sc, (43)Sc, and (48)V

用于生产治疗诊断放射性核素 (47)Sc、(46c)Sc、(44m)Sc、(44g)Sc、(43)Sc 和 (48)V 的富集 (48)Ti 靶上质子诱发反应的核截面

Mou, Liliana; De Dominicis, Lucia; Cisternino, Sara; Skliarova, Hanna; Campostrini, Matteo; Rigato, Valentino; De Nardo, Laura; Meléndez-Alafort, Laura; Esposito, Juan; Haddad, Férid; Pupillo, Gaia

Deficiency in coatomer complex I causes aberrant activation of STING signalling

衣壳蛋白复合物I的缺乏会导致STING信号异常激活

Annemarie Steiner ,Katja Hrovat-Schaale ,Ignazia Prigione ,Chien-Hsiung Yu ,Pawat Laohamonthonkul ,Cassandra R Harapas ,Ronnie Ren Jie Low ,Dominic De Nardo ,Laura F Dagley ,Michael J Mlodzianoski ,Kelly L Rogers ,Thomas Zillinger ,Gunther Hartmann ,Michael P Gantier ,Marco Gattorno ,Matthias Geyer ,Stefano Volpi ,Sophia Davidson # ,Seth L Masters #